Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EONS Poster diplay

4450 - EONS Poster - Increasing incidence and prevalence of immune-related adrenal insufficiency in patients with cancer: the role of the nurse practitioner for early recognition and management


22 Oct 2018


EONS Poster diplay


Management of Systemic Therapy Toxicities;  Immunotherapy;  Supportive Care and Symptom Management

Tumour Site


Chantal Roth


Annals of Oncology (2018) 29 (suppl_8): viii683-viii688. 10.1093/annonc/mdy276


C. Roth, M. Labots, A.J. Eertwegh

Author affiliations

  • Medical Oncology, Vrije University Medical Centre (VUMC), 1081 HV - Amsterdam/NL

Abstract 4450


Immune checkpoint inhibitors have improved the outcome of patients with advanced cancer significantly over the last decade. Disadvantageous effects of these novel treatments include auto-immune toxicities, named immune-related adverse events (irAEs), that most commonly affect the skin, gastrointestinal tract, liver and endocrine glands. Immune-related endocrine toxicities that involve the pituitary gland or adrenal glands may cause adrenal insufficiency (irAI), which can be life-threatening if not early recognized and managed.

Due to the expanding number of novel immunotherapies and indications, the number of patients with irAI will increase. We report a clinically applicable algorithm, with a key role for the nurse practitioner (NP), to manage irAI and to improve safety using a system-focused approach.


A collaboration between NP, oncologists and endocrinologists, taking input and perspectives from patients into account, was used to develop consensus regarding irAI management. Based on literature, institutional experience and group consensus, a clinically applicable algorithm was created.


Team members were educated on algorithm application and to improve safety. The NP was the first point of call and coordinated collaboration between patient, medical specialists and family physician. The NP was appointed a key role for patient education and information. Patients were educated to recognize symptoms of adrenal insufficiency and react promptly by increasing the dose of the corticosteroid substitution therapy. Patients were encouraged to contact the NP in case of problems or questions about the prophylactic dose of corticosteroids for stressful events.


Due to the increased use and the long-term efficacy of immune checkpoint inhibitors in patients with cancer, the incidence and prevalence of immune-related adrenal insufficiency (irAI) will increase. The here reported algorithm provides a streamlined approach for the management of irAI that is expected to improve safety and quality of life of patients.

Clinical trial identification

Legal entity responsible for the study

Van den Eertwegh AJM.


Has not received any funding.

Editorial Acknowledgement


M. Labots: Advisory board: BMS. J. Eertwegh: Advisory boards: BMS, Merck, Roche, Novartis, Amgen; Study grant: Roche. All other authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.